glp-1 drugs heart failure Impact of receptor agonists on hospitalization for and all-cause death in patients with diabetes with and without heart failure: a real-world study | Clinical Research in Cardiology Emerging Heart Failure Therapies in

Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes

The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031

A new case series presents a unique paradox where GLP-1 RA therapy improved quality of life and resolved diarrhea in two women with

For .epub and audiobook purchases, you will receive instant delivery of the following digital files*

Learn about the benefits and savings opportunities of the SmithRx Weight Management Pathway.

An analysis of PBM tension, the Newkirk litigation, Anthems GLP-1 coverage issues, and emerging risks in pharmacy benefit plan design.